1.
Genotype-specific effects of smoking on risk of CHD
by Li Wang, Xing
The Lancet (British edition), 2001, Vol.358 (9276), p.87-88

2.
Platelet alloantigens: cardiovascular as well as immunological risk factors?
by Newman, Peter J
The Lancet (British edition), 1997, Vol.349 (9049), p.370-371

3.
Understanding cardiovascular development
by Grace, A A
The Lancet (British edition), 1995-04-08, Vol.345 (8954), p.915

4.
Clinical assessment incorporating a personal genome
by Ashley, Euan A, Dr
The Lancet (British edition), 2010, Vol.375 (9725), p.1525-1535

5.
Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials
by Mega, Jessica L, Dr
The Lancet (British edition), 2015, Vol.385 (9984), p.2264-2271

6.
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLAT...
by Wallentin, Lars, Prof
The Lancet (British edition), 2010, Vol.376 (9749), p.1320-1328

7.
Hypertrophic cardiomyopathy
by Elliott, Perry
The Lancet (British edition), 2004-06-05, Vol.363 (9424), p.1881-1891

8.
Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial
by Roberts, Jason D, MD
The Lancet (British edition), 2012, Vol.379 (9827), p.1705-1711

9.
Genome-wide mapping of human loci for essential hypertension
by Caulfield, Mark
The Lancet (British edition), 2003-06-21, Vol.361 (9375), p.2118-2123

10.
Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk
by Lim, Bernard CB
The Lancet (British edition), 2003-04-26, Vol.361 (9367), p.1424-1431

12.
Cardiovascular gene therapy
by Ylä-Herttuala, Seppo
The Lancet (British edition), 2000, Vol.355 (9199), p.213-222

13.
Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease
by Katsuya, T
The Lancet (British edition), 1995-06-24, Vol.345 (8965), p.1600-1603

14.
Statins and type 2 diabetes: genetic studies on target
by Frayling, Timothy M
The Lancet (British edition), 2015, Vol.385 (9965), p.310-312

15.
Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease)
by McKoy, Godfrina
The Lancet (British edition), 2000, Vol.355 (9221), p.2119-2124

16.
Nature's randomised trials
by Hingorani, Aroon
The Lancet (British edition), 2005-12-03, Vol.366 (9501), p.1906-1908

17.
C-reactive protein and its role in metabolic syndrome: mendelian randomisation study
by Timpson, Nicholas J
The Lancet (British edition), 2005-12-03, Vol.366 (9501), p.1954-1959

18.
Pathogenesis and genetics of pre-eclampsia
by Roberts, JM
The Lancet (British edition), 2001, Vol.357 (9249), p.53-56

19.
Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight
by VAESSEN, Norbert
The Lancet (British edition), 2002, Vol.359 (9311), p.1036-1037

20.
Four paraoxonase gene polymorphisms in 11 212 cases of coronary heart disease and 12 786 controls: meta-analysis of 43 studies
by Wheeler, Jeremy G
The Lancet (British edition), 2004, Vol.363 (9410), p.689-695
